Document
IPR2016-01582, No. 2047-126 Exhibit - JSN 2047 Stamey et al, ¿¿¿Prostate Specific Antigen As A Serum Marker For Adenocarcinoma Of The Prostate,¿¿¿ NEJM, 31715909 916 1987 (P.T.A.B. Ma...
Cite Document
IPR2016-01582, No. 2047-126 Exhibit - JSN 2047 Stamey et al, ¿¿¿Prostate Specific Antigen As A Serum Marker For Adenocarcinoma Of The Prostate,¿¿¿ NEJM, 31715909 916 1987 (P.T.A.B. Mar. 17, 2017)
+ More Snippets
Document
IPR2016-01582, No. 1072-71 Exhibit - UBS Zytiga Label Extended (P.T.A.B. Aug. 10, 2016)
Cite Document
IPR2016-01582, No. 1072-71 Exhibit - UBS Zytiga Label Extended (P.T.A.B. Aug. 10, 2016)
+ More Snippets
Document
IPR2016-01582, No. 1022-21 Exhibit - Attard 2009 (P.T.A.B. Aug. 10, 2016)
Cite Document
IPR2016-01582, No. 1022-21 Exhibit - Attard 2009 (P.T.A.B. Aug. 10, 2016)
+ More Snippets
Document
IPR2016-01582, No. 2139-209 Exhibit - JSN 2139 JJ Q1 2013 Earnings Call Transcript (P.T.A.B. Mar. 17, 2017)
Cite Document
IPR2016-01582, No. 2139-209 Exhibit - JSN 2139 JJ Q1 2013 Earnings Call Transcript (P.T.A.B. Mar. 17, 2017)
+ More Snippets
Document
IPR2016-01582, No. 1122-276 Exhibit - Second Declaration of Robert D Stoner, PhD Redacted (P.T.A.B. Apr. 19, 2017)
Cite Document
IPR2016-01582, No. 1122-276 Exhibit - Second Declaration of Robert D Stoner, PhD Redacted (P.T.A.B. Apr. 19, 2017)
+ More Snippets
Document
IPR2016-01582, No. 1025-24 Exhibit - Kelly 1993 (P.T.A.B. Aug. 10, 2016)
Cite Document
IPR2016-01582, No. 1025-24 Exhibit - Kelly 1993 (P.T.A.B. Aug. 10, 2016)
+ More Snippets
Document
IPR2016-01582, No. 1032-31 Exhibit - The Pharmacological Basis of Therapeutics 1990 (P.T.A.B. Aug. 10, 2016)
Cite Document
IPR2016-01582, No. 1032-31 Exhibit - The Pharmacological Basis of Therapeutics 1990 (P.T.A.B. Aug. 10, 2016)
+ More Snippets
Document
IPR2016-01582, No. 2138-208 Exhibit - JSN 2138 BTG Annual Report, 2004 (P.T.A.B. Mar. 17, 2017)
Cite Document
IPR2016-01582, No. 2138-208 Exhibit - JSN 2138 BTG Annual Report, 2004 (P.T.A.B. Mar. 17, 2017)
+ More Snippets
Document
IPR2016-01582, No. 2026-107 Exhibit - JSN 2026 Remington ¿¿¿ The Science and Practice of Pharmacy, 20th ed, pp 1363 1370 2000 (P.T.A.B. Mar. 17, 2017)
Cite Document
IPR2016-01582, No. 2026-107 Exhibit - JSN 2026 Remington ¿¿¿ The Science and Practice of Pharmacy, 20th ed, pp 1363 1370 2000 (P.T.A.B. Mar. 17, 2017)
+ More Snippets
Document
IPR2016-01582, No. 2108-185 Exhibit - JSN 2108 Orange Book ¿¿¿ Jevtana (P.T.A.B. Mar. 17, 2017)
Cite Document
IPR2016-01582, No. 2108-185 Exhibit - JSN 2108 Orange Book ¿¿¿ Jevtana (P.T.A.B. Mar. 17, 2017)
+ More Snippets
Document
IPR2016-01582, No. 1076-75 Exhibit - hurdle rate definition (P.T.A.B. Aug. 10, 2016)
Cite Document
IPR2016-01582, No. 1076-75 Exhibit - hurdle rate definition (P.T.A.B. Aug. 10, 2016)
+ More Snippets
Document
IPR2016-01582, No. 1035-34 Exhibit - Potter 1995 (P.T.A.B. Aug. 10, 2016)
Cite Document
IPR2016-01582, No. 1035-34 Exhibit - Potter 1995 (P.T.A.B. Aug. 10, 2016)
+ More Snippets
Document
IPR2016-01582, No. 2148-218 Exhibit - JSN 2148 JJ Q2 2015 Earnings Call Transcript (P.T.A.B. Mar. 17, 2017)
Cite Document
IPR2016-01582, No. 2148-218 Exhibit - JSN 2148 JJ Q2 2015 Earnings Call Transcript (P.T.A.B. Mar. 17, 2017)
+ More Snippets
Document
IPR2016-01582, No. 2012-93 Exhibit - JSN 2012 PM Live Top 50 Pharmaceuticals (P.T.A.B. Mar. 17, 2017)
Cite Document
IPR2016-01582, No. 2012-93 Exhibit - JSN 2012 PM Live Top 50 Pharmaceuticals (P.T.A.B. Mar. 17, 2017)
+ More Snippets
Document
IPR2016-01582, No. 2062-141 Exhibit - JSN 2062 Craft, ¿¿¿Eplerenone Inspra, a new aldosterone antagonist for the treatment of systemic hypertension and heart failure,¿¿¿ BUMC Proceedings, 1...
Cite Document
IPR2016-01582, No. 2062-141 Exhibit - JSN 2062 Craft, ¿¿¿Eplerenone Inspra, a new aldosterone antagonist for the treatment of systemic hypertension and heart failure,¿¿¿ BUMC Proceedings, 17217 220 20
+ More Snippets